A5059221006- COVID-19 Clinical Research Studies
- Long-Term Effects of COVID-19
- COVID-19 Impact on Reproduction
- Respiratory Support and Mechanisms
- COVID-19 and healthcare impacts
- Pregnancy and Medication Impact
- Reproductive System and Pregnancy
- SARS-CoV-2 and COVID-19 Research
- Inflammatory Biomarkers in Disease Prognosis
- Adipokines, Inflammation, and Metabolic Diseases
- Intensive Care Unit Cognitive Disorders
Centro Médico ABC
2023
Mexican Social Security Institute
2020-2023
Centro Medico Nacional Siglo XXI
2020-2023
Hospital de Especialidades
2020-2022
Acute Respiratory Distress Syndrome (ARDS) due tocoronavirus disease (COVID-19) infection has a unique phenotype generating growing need to determine the existing differences that can alter evidence-based management strategies for ARDS.What does clinical profile of patients with ARDS COVID 19 and Non-COVID have?We conducted comparative, observational, retrospective study in Intensive Care Unit (ICU)of third-level hospital Mexico City, from March 2020 through 2022. Clinical,...
Current medical guidelines consider pregnant women with COVID-19 to be a high-risk group. Since physiological gestation downregulates the immunological response maintain “maternal-fetal tolerance”, SARS-CoV-2 infection may constitute potentially threatening condition both mother and fetus. To establish immune profile in COVID-19+ patients, cross-sectional study was conducted. Pregnant (P-COVID-19+; n = 15) were analyzed compared nonpregnant (NP-COVID-19+; or those pregnancy (P-COVID-19-;...
On January 30th, 2020, the WHO declared outbreak of COVID19, a disease due to new coronavirus called SARS-CoV-2. Certain comorbidities, symptoms and signs are characteristic COVID19 in general population pregnant women. However, women considered as high-risk group for COVID19. To know about frequency symptoms, presence lymphopenia, antibodies response SARS-CoV2 cytokine chemokine serum concentration, six with were studied at moment admission. The lower concentration CCL17 was detected...
The difficulty in predicting fatal outcomes patients with coronavirus disease 2019 (COVID-19) impacts the general morbidity and mortality due to severe acute respiratory syndrome-coronavirus 2 infection, as it wears out hospital services that care for these patients. Unfortunately, several of candidates prognostic biomarkers proposed, predictive power is compromised when have pre-existing comorbidities. A cohort 147 hospitalized COVID-19 was included a descriptive, observational,...
Abstract Current medical guidelines consider COVID-19 pregnant women a high-risk group. Physiological gestation down regulates the immunological response to maintain “maternal-fetal tolerance”; hence, SARS-CoV-2 infection constitutes potentially threatening condition both mother and fetus. To establish immune profile in COVID-19+ patients cross-sectional study was conducted. Leukocyte immunophenotype, mononuclear leukocyte polyclonal stimulus cytokine/chemokine serum concentration were...
RESUMEN.Desde el inicio de la pandemia por COVID-19, dentro las complicaciones más frecuentes esta infección se encuentran neumonía y síndrome dificultad respiratoria aguda.La hipoxemia aumento del trabajo respiratorio son determinantes para adoptar diversas estrategias terapéuticas oxigenación no invasiva en pacientes con COVID-19.Es importante conocer describir diferentes modalidades oxigenoterapia invasiva, finalidad preservar un adecuado respiratorio, descritas literatura abarcan:...
Abstract Background The difficulty to predict fatal outcomes in COVID-19 patients, impacts the general morbidity and mortality due SARSCoV2 infection, as it wears out hospital services that care for these patients. Unfortunately, several of candidates prognostic biomarkers proposed, predictive power is compromised when patients have pre-existing co-morbidities. Methods A cohort one hundred forty-seven hospitalized severe COVID19 was included a descriptive, observational, single-center,...